Intracellular Casp8p41 content is inversely associated with CD4 T cell count

Journal of Infectious Diseases

Volumn 202, Issue 3, 2010, Pages 386-391

  Cummins, Nathan W ^a   Jiang, Wei ^d   McGinty, John ^b   Bren, Gary D ^a   Bosch, Ronald J ^e   Landay, Alan ^f   Deeks, Steven G ^g   Martin, Jeffrey N ^g   Douek, Daniel ^c   Lederman, Michael M ^d   Brenchley, Jason ^b   Badley, Andrew D ^a  

^a MAYO CLINIC   (United States)

^b Laboratory of Molecular Pharmacology   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CD4 ANTIGEN; PROCASPASE 8; PROTEIN; PROTEIN CASP8P41; PROTEINASE; UNCLASSIFIED DRUG; VIRUS DNA; CASP8 PROTEIN, HUMAN; CASPASE 8;

ARTICLE; CD4 LYMPHOCYTE COUNT; CELL DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MEMORY CELL; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; ADULT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMISTRY; CROSS-SECTIONAL STUDY; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOGENICITY; PATHOLOGY;

ADULT; CASPASE 8; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; FEMALE; HIV; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 77954722968     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/653705     Document Type: Article

References (14)

1. Meyaard L, Otto SA, Keet IP, Roos MT, Miedema F. Programmed death of T cells in human immunodeficiency virus infection: no correlation with progression to disease. J Clin Invest 1994; 93:982-988.
2. Pandolfi F, Pierdominici M, Oliva A, et al. Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9:450-458.
3. Gougeon ML, Lecoeur H, Dulioust A, et al. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol 1996; 156: 3509-3520.
4. Samuelsson A, Brostrom C, van Dijk N, Sonnerborg A, Chiodi F. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection-correlation with clinical progression, viral load, and loss of humoral immunity. Virology 1997; 238:180-188.
5. Rothen M, Gratzl S, Hirsch HH, Moroni C. Apoptosis in HIV-infected individuals is an early marker occurring independently of high viremia. AIDS Res Hum Retroviruses 1997; 13:771-779.
6. Nie Z, Phenix BN, Lum JJ, et al. HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation. Cell Death Differ 2002; 9:1172-1184.
7. Nie Z, Bren GD, Vlahakis SR, et al. Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo. J Virol 2007; 81:6947-6956.
8. Algeciras-Schimnich A, Belzacq-Casagrande AS, Bren GD, et al. Analysis of HIV protease killing through Caspase 8 reveals a novel interaction between Caspase 8 and mitochondria. Open Virol J 2007; 1:39-46.
9. Nie Z, Bren GD, Rizza SA, Badley AD. HIV protease cleavage of procaspase 8 is necessary for death of HIV-infected cells. Open Virol J 2008; 2:1-7.
10. Bren GD, Whitman J, Cummins N, et al. Infected cell killing by HIV- 1 protease promotes NF-kappaB dependent HIV-1 replication. PLoS ONE 2008; 3:e2112.
11. Landay AL, Spritzler J, Kessler H, et al. Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor-containing antiretroviral regimen. J Infect Dis 2003; 188: 1444-1454.
12. Jiang W, Lederman MM, Hunt P, et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 2009; 199(8):1177-1185.
13. Brenchley JM, Hill BJ, Ambrozak DR, et al. T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J Virol 2004; 78:1160-1168.
14. Rodriguez B, Sethi AK, Cheruvu VK, et al. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 2006; 296:1498-1506.